Functional proteomic aberrations post-chemotherapy with paclitaxel and carboplatin in patients with advanced ovarian cancer

被引：0
|
作者：
Lee, Sanghoon [1 ]
Zhao, Li [1 ]
Celestino, Joseph [1 ]
Rangel, Kelly M. [1 ]
Hajek, Richard A. [1 ]
Kim, Mark S. [1 ]
Sharafi, Sara E. [1 ]
Liu, Jinsong [1 ]
Fleming, Nicole D. [1 ]
Lu, Karen H. [1 ]
Zhang, Jianhua [1 ]
Futreal, P. Andrew [1 ]
Mills, Gordon B. [2 ]
Westin, Shannon N. [1 ]
Sood, Anil K. [1 ]
Jazaeri, Amir A. [1 ]
Coleman, Robert L. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-2941
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2941
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reversible posterior leukoencephalopathy post-chemotherapy with carboplatin and paclitaxel
    Jamelot, Mathieu
    Fontanilles, Maxime
    Vaschalde, Yvan
    BULLETIN DU CANCER, 2019, 106 (12) : 1191 - 1195
  • [2] The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
    Xia Wu
    Qin-Mei Feng
    Ying Wang
    Jun Shi
    Hai-Liang Ge
    Wen Di
    Cancer Immunology, Immunotherapy, 2010, 59 : 279 - 291
  • [3] The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
    Wu, Xia
    Feng, Qin-Mei
    Wang, Ying
    Shi, Jun
    Ge, Hai-Liang
    Di, Wen
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (02) : 279 - 291
  • [4] Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Martin Pölcher
    Meike Eckhardt
    Christoph Coch
    Matthias Wolfgarten
    Kirsten Kübler
    Gunther Hartmann
    Walther Kuhn
    Christian Rudlowski
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 203 - 207
  • [5] Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Poelcher, Martin
    Eckhardt, Meike
    Coch, Christoph
    Wolfgarten, Matthias
    Kuebler, Kirsten
    Hartmann, Gunther
    Kuhn, Walther
    Rudlowski, Christian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 203 - 207
  • [6] Evaluation of Retinal Nerve Fiber Layer and Macular Thickness Pre- and Post-Chemotherapy With Carboplatin and Paclitaxel in Patients With Endometrial and Ovarian Cancer
    Chin, Ju Juen
    Hitam, Wan-Hazabbah Wan
    Chong, Mei Fong
    Lee, Saw Joo
    Yew, Jing Mun
    Ngoo, Qi Zhe
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [7] Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advanced ovarian cancer
    Watanabe, M
    Aoki, Y
    Tomita, M
    Sato, T
    Takaki, Y
    Kato, N
    Kikuchi, M
    Kase, H
    Tanaka, K
    GYNECOLOGIC ONCOLOGY, 2002, 84 (02) : 335 - 338
  • [8] Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer
    Ozols, RF
    SEMINARS IN ONCOLOGY, 2000, 27 (03) : 3 - 7
  • [9] Tolerance of weekly paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin
    Dessai, S. B.
    Chakraborty, S.
    Babu, T. V. S.
    Nayanar, S.
    Bhattacharjee, A.
    Jones, J.
    Balasubramanian, S.
    Patil, V. M.
    INDIAN JOURNAL OF CANCER, 2016, 53 (02) : 280 - 283
  • [10] Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer
    Méndez, LE
    Mueller, A
    Salom, E
    González-Quintero, VH
    OBSTETRICS AND GYNECOLOGY, 2003, 102 (05): : 1200 - 1202
12345